Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Journal of Vascular Surgery
|
March 13, 2010
Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury
Nick D Tsihlis, Jozef Murar, Muneera R Kapadia, et al.
Biomaterials
|
November 25, 2023
Systemic peptide amphiphile nanofiber delivery following subcutaneous injection
Mark H Barlek, David C Gillis, Simon A Egner, et al.
Bioactive Materials
|
December 31, 2025
Ascorbate elastomer-coated ePTFE grafts inhibit neointimal hyperplasia and enhance vascular healing
Lu Yu, Emily R Newton, David C Gillis, et al.
Biomaterials Science
|
July 27, 2021
Coating small-diameter ePTFE vascular grafts with tunable poly(diol-co-citrate-co-ascorbate) elastomers to reduce neointimal hyperplasia
Lu Yu, Emily R Newton, David C Gillis, et al.
The Journal of Surgical Research
|
November 21, 2012
Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury
George E Havelka, Edward S Moreira, Monica P Rodriguez, et al.
The Journal of Surgical Research
|
May 6, 2026
Nitric Oxide-releasing Nanofibers Prevent Restenosis After Arterial Injury in a Renal Failure Model
C Chase Binion, Paige A Tannhauser, Mark H Barlek, et al.
Advanced Healthcare Materials
|
January 9, 2019
Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery
Erica B Peters, Nick D Tsihlis, Mark R Karver, et al.
Advanced Therapeutics
|
December 20, 2021
Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche
Erica B Peters, Mark R Karver, Kui Sun, et al.
Advanced Nanobiomed Research
|
August 22, 2025
Evaluation of a Targeted Drug-Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model
Emily R Newton, David C Gillis, Kui Sun, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 22, 2008
Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome
Sadaf S Ahanchi, Vinit N Varu, Nick D Tsihlis, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Journal of Vascular Surgery
|
March 13, 2010
Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury
Nick D Tsihlis, Jozef Murar, Muneera R Kapadia, et al.
Biomaterials
|
November 25, 2023
Systemic peptide amphiphile nanofiber delivery following subcutaneous injection
Mark H Barlek, David C Gillis, Simon A Egner, et al.
Bioactive Materials
|
December 31, 2025
Ascorbate elastomer-coated ePTFE grafts inhibit neointimal hyperplasia and enhance vascular healing
Lu Yu, Emily R Newton, David C Gillis, et al.
Biomaterials Science
|
July 27, 2021
Coating small-diameter ePTFE vascular grafts with tunable poly(diol-co-citrate-co-ascorbate) elastomers to reduce neointimal hyperplasia
Lu Yu, Emily R Newton, David C Gillis, et al.
The Journal of Surgical Research
|
November 21, 2012
Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury
George E Havelka, Edward S Moreira, Monica P Rodriguez, et al.
The Journal of Surgical Research
|
May 6, 2026
Nitric Oxide-releasing Nanofibers Prevent Restenosis After Arterial Injury in a Renal Failure Model
C Chase Binion, Paige A Tannhauser, Mark H Barlek, et al.
Advanced Healthcare Materials
|
January 9, 2019
Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery
Erica B Peters, Nick D Tsihlis, Mark R Karver, et al.
Advanced Therapeutics
|
December 20, 2021
Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche
Erica B Peters, Mark R Karver, Kui Sun, et al.
Advanced Nanobiomed Research
|
August 22, 2025
Evaluation of a Targeted Drug-Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model
Emily R Newton, David C Gillis, Kui Sun, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 22, 2008
Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome
Sadaf S Ahanchi, Vinit N Varu, Nick D Tsihlis, et al.
Page
of 4